Weifeng Li

Weifeng Li

Auto-generated profile, based on publicly available information

Weifeng Li

Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2022 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
MSMatthew D. Smith
Matthew D. Smith
XCXitiz Chamling
Xitiz Chamling
AGAlexander Gill
Alexander Gill
HMHector Martinez
Hector Martinez
WLWeifeng Li
Weifeng Li
PCPeter A Calabresi
Peter A Calabresi
Astrocytes are instrumental in maintaining central nervous system (CNS) homeostasis and responding to injury. A major limitation of studying neurodegenerative diseases like multiple sclerosis (MS) is lack of human pathological specimens obtained during the acute stages, thereby relegating research to post-mortem specimens obtained years after the initiation of pathology. Rodent reactive astrocytes have been shown to be cytotoxic to neurons and oligodendrocytes but may differ from human cells, especially in diseases with genetic susceptibility. Herein, we purified human CD49f+ astrocytes from induced pluripotent stem cells derived from individual patient and control peripheral leukocytes. We compared TNF and IL1α stimulated human reactive astrocytes from seven persons with MS and six non-MS controls and show their transcriptomes are remarkably similar to those described in rodents. The functional effect of astrocyte conditioned media (ACM) was examined in a human oligodendrocyte precursor cell (OPC) line differentiation assay. ACM was not cytotoxic to the OPCs but robustly inhibited the myelin basic protein (MBP) reporter. No differences were seen between MS and control stimulated astrocytes at either the transcript level or in ACM mediated OPC suppression assays. We next used RNAseq to interrogate differentially expressed genes in the OPC lines that had suppressed differentiation from the human ACM. Remarkably, not only was OPC differentiation and myelin gene expression suppressed, but we observed induction of several immune pathways in OPCs exposed to the ACM. These data support the notion that reactive astrocytes can inhibit OPC differentiation thereby limiting their remyelination capacity, and that OPCs take on an immune profile in the context of inflammatory cues.

8 February 2023 in iScience
Verified
Journal Article
Open access
WLWeifeng Li
Weifeng Li
CBCynthia Berlinicke
Cynthia Berlinicke
YHYinyin Huang
Yinyin Huang
SGStefanie Giera
Stefanie Giera
AMAnna G. McGrath
Anna G. McGrath
XCXitiz Chamling
Xitiz Chamling
Promoting myelination capacity of endogenous oligodendrocyte precursor cells (OPCs) is a promising therapeutic approach for CNS demyelinating disorders such as Multiple Sclerosis (MS). To aid in the discovery of myelination-promoting compounds, we generated a genome-engineered human pluripotent stem cell (hPSC) line that consists of three reporters: identification-and-purification tag, GFP, and secreted-NanoLuc, driven by the endogenous PDGFRA, PLP1, and MBP genes, respectively. Using this cell line, we established a high-throughput drug screening platform and performed a small-molecule screen, which identified at least two myelination-promoting small-molecule (Ro1138452 and SR2211) that target prostacyclin (IP) receptor and retinoic acid receptor-related orphan receptor γ (RORγ), respectively. Single-cell-transcriptomic analysis of differentiating OPCs treated with these molecules further confirmed that they promote oligodendrocyte differentiation and revealed several pathways that are potentially modulated by them. The molecules and their target pathways provide promising targets for the possible development of remyelination-based therapy for MS and other demyelinating disorders.

28 August 2024 in Journal of Building Engineering
Verified
Journal Article
Closed access
GQGuanhua Qu
Guanhua Qu
ZLZenghui Liu
Zenghui Liu
LRLei Ren
Lei Ren
GLGang Liu
Gang Liu
YZYuanyuan Zhang
Yuanyuan Zhang
WLWeifeng Li
Weifeng Li